Up-regulation of POM121 is linked to prostate cancer aggressiveness and serves as a prognostic biomarker.
Becker F, Offermann A, Roesch MC, Joerg V, Roth D, Lubczyk V, Kuefer R, Sailer V, Kirfel J, Merseburger AS, et al. Urol Oncol. 2022 Aug; 40(8):380.e11-380.e18. Epub 2022 Jun 17.